Nephrology News

Researchers from Italy observed a “drastic” reduction in central venous catheter-related infections after hygienic procedures were implemented at hemodialysis facilities as a response to the COVID-19 pandemic.

Approximately 10% to 17% of patients with type 2 diabetes and newly identified chronic kidney disease had their condition worsen within 2 years, according to a study published in the Clinical Kidney Journal.

Healio Primary Care is pleased to announce the creation of its Peer Perspective Board — a group of dedicated experts who will help guide our efforts to provide the latest news and updates that impact daily practice.

Breaking news and emerging research on the COVID-19 pandemic dominated headlines this year. However, there were other important updates that impact practice.

Researchers at Medical University of South Carolina have developed a telehealth platform that they deemed successful at ensuring the kidney transplantation process continues during the COVID-19 pandemic.

A majority of patients with kidney failure were deemed ready for increased utilization of mobile health based on reported availability of necessary devices, as well as proficiency and interest in the technology.

President Donald J. Trump today approved a legislative package that includes lifetime coverage of immunosuppressants for kidney transplant recipients.

The U.S. Senate voted in favor of legislation that extends Medicare coverage of immunosuppressants to all kidney transplant recipients, regardless of age, and ensures these medications are covered for life.

The National Kidney Foundation has released a statement urging the federal government to grant priority to patients with kidney disease and their contacts for receipt of COVID-19 vaccines.

Data from Italy indicate the impact of COVID-19 is not greater for children with chronic kidney disease or immunosuppression compared with a pediatric cohort who have neither condition.